Compare LGIH & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGIH | OPK |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2013 | 1995 |
| Metric | LGIH | OPK |
|---|---|---|
| Price | $43.86 | $1.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $71.13 | $2.28 |
| AVG Volume (30 Days) | 352.5K | ★ 4.0M |
| Earning Date | 02-24-2026 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.53 | N/A |
| Revenue | ★ $1,788,933,000.00 | $642,067,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.56 | N/A |
| P/E Ratio | $9.44 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $39.70 | $1.11 |
| 52 Week High | $97.25 | $2.04 |
| Indicator | LGIH | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 50.24 |
| Support Level | $41.30 | $1.24 |
| Resistance Level | $43.77 | $1.33 |
| Average True Range (ATR) | 1.62 | 0.05 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 34.71 | 57.14 |
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.